Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
BMJ Case Reports|February 14, 2025
Cranial nerve III palsy induced by adjuvant capecitabine for cholangiocarcinomaMaurice Dungey, Norene Ashmore, Sean DullooNature Reviews. Clinical Oncology|July 1, 2022
Immunotherapy approaches for malignant pleural mesotheliomaDean A Fennell, Sean Dulloo, James HarberCancers|June 2, 2021
Precision Therapy for Mesothelioma: Feasibility and New OpportunitiesSean Dulloo, Aleksandra Bzura, Dean Anthony FennellTrends in Cancer|April 2, 2026
Mesothelioma: a systemic therapy clinical trials snapshotMaurice Dungey, Rushad Malhotra Mukhtyar, Sean Dulloo, et al.Drugs|July 13, 2024
Targeting DNA Damage Response Deficiency in Thoracic CancersAleksandra Bzura, Jake B Spicer, Sean Dulloo, et al.British Journal of Nursing (Mark Allen Publishing)|April 19, 2025
Decentralising delivery of systemic anti-cancer therapy (SACT) with subcutaneous atezolizumab: service challenges, opportunities and case studiesElaine Tomlins, Helen Winter, Anna Olsson-Brown, et al.BMJ Open|November 22, 2023
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centresDean Fennell, Daniel Griffiths, Zina Eminton, et al.Nature Communications|July 14, 2026
Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancerVictoria Gibson, Joanna Dzialo, Terri Messier, et al.Pageof 1